Memorial Sloan-Kettering Cancer Center Commack: Clinical Trials at Commack

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan-Kettering Cancer Center Commack below. You can also explore our complete listing of clinical trials available at Memorial Sloan-Kettering.

Showing 41 - 60 of 91 trials
Title Investigatorsort icon Disease(s)
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120] 		Kaley, Thomas
  • Brain Tumors, Primary
    • Gliomas
  • Pediatric Brain Tumors
    • Brain Cancer
Early Onset and Familial Gastric Cancer Registry
[Protocol 05-118] 		Kelsen, David
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137] 		Kemeny, Nancy
  • Colorectal Cancer
A Phase III Study of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
[Protocol 11-190] 		King, Tari
  • Breast Cancer
A Prospective Phase II Study of Brachytherapy in Men with Prostate Cancer that Returned after Prior External Beam Radiation Therapy
[Protocol 12-098] 		Kollmeier, Marisa
  • Prostate Cancer
    • Localized Disease
    • Rising PSA After Primary Therapy
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031] 		Kollmeier, Marisa
  • Bladder Cancer
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053] 		Krug, Lee
  • Mesothelioma
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118] 		Lake, Diana
  • Breast Cancer
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
[Protocol 09-171] 		Landau, Heather
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
    • Sibling and Unrelated Volunteer
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
A Phase II Study of Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
[Protocol 11-005] 		Lee, Nancy
  • Head & Neck Cancer
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081] 		Lee, Nancy
  • Head & Neck Cancer
Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients
[Protocol 04-070] 		Lee, Nancy
  • Head & Neck Cancer
A Phase II Study of IZN-6N4 to Reduce Mouth Sores in Patients with Head and Neck Cancer Receiving Chemotherapy and Radiation Therapy
[Protocol 12-204] 		Lee, Nancy
  • Head & Neck Cancer
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact in Newly Diagnosed Patients
[Protocol 12-190] 		Leitao, Mario
  • Cervical Cancer
  • Endometrial and other Uterine Cancers
    • Uterine Cancer
  • Vulvar Cancer
A Phase II Study of Siltuximab in Patients with High-Risk Smoldering Multiple Myeloma
[Protocol 12-068] 		Lesokhin, Alexander
  • Hematology
    • Multiple Myeloma
Development of Group Interventions for Breast Cancer Survivors
[Protocol 12-291] 		Lichtenthal, Wendy
  • Breast Cancer
  • Survivorship
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152] 		McCormick, Beryl
  • Breast Cancer
A Pilot Study of Weekly High-Dose Erlotinib for Recurrent High-Grade Gliomas with the EGFR variant III Mutation
[Protocol 10-125] 		Mellinghoff, Ingo
  • Brain Tumors, Primary
    • Gliomas
  • Pediatric Brain Tumors
    • Brain Cancer
Risk-Adapted Therapy for Patients With Untreated Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B-Cell Lymphoma
[Protocol 08-026] 		Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Everolimus as Second-Line Therapy in the Treatment of Metastatic Renal Cell Carcinoma
[Protocol 11-197] 		Motzer, Robert
  • Kidney Cancer